Jiaxing Huahe Pharmaceutical Co., Ltd.

About Jiaxing Huahe Pharmaceutical Co., Ltd.

A Other / Uncategorized player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• BioPharma Reporter · 2026-10-19
  Jiaxing Huahe Pharmaceutical Co Ltd publishes dosimetry data at SNMMI 2026
  The announcement comes amid tightening Mo-99 and Lu-177 supply.
• FierceBiotech · 2026-05-12
  Jiaxing Huahe Pharmaceutical Co Ltd closes Series C round to scale radiopharma manufacturing
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Endpoints News · 2026-08-21
  Jiaxing Huahe Pharmaceutical Co Ltd partners with academic center on Actinium-225 program
  Details remain limited but analysts read the move as a positioning play ahead of pivotal data.
• Reuters Health · 2026-11-14
  Jiaxing Huahe Pharmaceutical Co Ltd files IND for next-generation PSMA-targeted agent
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.